![]() |
Volumn 256, Issue 1, 2009, Pages 3-12
|
Cerebrospinal fluid biomarkers in Guillain-Barré syndrome - Where do we stand?
|
Author keywords
Biomarkers; Cerebrospinal fluid; Guillain Barr syndrome
|
Indexed keywords
BIOLOGICAL MARKER;
COMPLEMENT COMPONENT C3A;
COMPLEMENT COMPONENT C4D;
COMPLEMENT COMPONENT C5A;
COMPLEMENT MEMBRANE ATTACK COMPLEX;
CYSTATIN C;
GAMMA INTERFERON INDUCIBLE PROTEIN 10;
GANGLIOSIDE ANTIBODY;
INTERLEUKIN 1;
INTERLEUKIN 2;
INTERLEUKIN 2 RECEPTOR;
INTERLEUKIN 4;
INTERLEUKIN 6;
MONOCYTE CHEMOTACTIC PROTEIN 1;
MYELIN BASIC PROTEIN;
NEURON SPECIFIC ENOLASE;
OREXIN A;
PROTEIN 14 3 3;
PROTEIN S100B;
TAU PROTEIN;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR RECEPTOR;
ARTICLE;
BLOOD BRAIN BARRIER;
CEREBROSPINAL FLUID;
COMPLEMENT FACTOR;
CONCENTRATION (PARAMETERS);
DISEASE MARKER;
GLIA CELL;
GUILLAIN BARRE SYNDROME;
HUMAN;
MYELIN SHEATH;
NERVE CELL;
NEUROFILAMENT;
PATHOPHYSIOLOGY;
POLYACRYLAMIDE GEL ELECTROPHORESIS;
PRIORITY JOURNAL;
PROGNOSIS;
SPINAL ROOT;
TWO DIMENSIONAL GEL ELECTROPHORESIS;
14-3-3 PROTEINS;
AXONS;
BIOLOGICAL MARKERS;
CEREBROSPINAL FLUID PROTEINS;
GUILLAIN-BARRE SYNDROME;
HUMANS;
MYELIN BASIC PROTEINS;
NEUROGLIA;
NEURONS;
PHOSPHOPYRUVATE HYDRATASE;
PREDICTIVE VALUE OF TESTS;
PROGNOSIS;
|
EID: 62149129699
PISSN: 03405354
EISSN: 14321459
Source Type: Journal
DOI: 10.1007/s00415-009-0097-x Document Type: Article |
Times cited : (53)
|
References (80)
|